Neoadjuvant Chemotherapy in Non Small Cell Lung Cancer (NSCLC) Stages IB, IIA, IIB, and IIIA/T3
NCT00273507 · Status: TERMINATED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 270
Last updated 2009-09-18
Summary
Randomised trial of chemotherapy or not before surgery in early resectable stages of NSCLC (IB, IIA, IIB, and IIIA/N2).
Conditions
Interventions
- DRUG
-
Carboplatin and Paclitaxel
Sponsors & Collaborators
-
Rigshospitalet, Denmark
lead OTHER
Principal Investigators
-
Jens B. Sorensen, MD · Dept. Oncology, Rigshospitalet
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 1998-01-31
- Completion
- 2006-01-31
Countries
- Denmark
Study Locations
More Related Trials
-
Preoperative Therapy in Patients With Stages IB, II, IIIA, and Selected IIIB Patients With Non-Small Cell Lung Cancer
NCT00193427 ·Status: COMPLETED ·Phase: PHASE2
-
S0342: Paclitaxel, Carboplatin, and Cetuximab in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
NCT00085501 ·Status: COMPLETED ·Phase: PHASE2
-
An Investigational Immuno-therapy Study of Nivolumab Given After Surgery in Non-Small Cell Lung Cancer (NSCLC) Participants With Minimal Residual Disease
NCT03770299 ·Status: WITHDRAWN ·Phase: PHASE2
-
Docetaxel, Carboplatin, and Bevacizumab in Treating Patients With Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer That Can Be Removed By Surgery
NCT00293332 ·Status: TERMINATED ·Phase: PHASE2
-
Surgery With or Without Chemotherapy in Treating Patients With Stage I Non-small Cell Lung Cancer
NCT00002852 ·Status: COMPLETED ·Phase: PHASE3
-
A Randomized Phase 2 Study of Ixabepilone Plus Carboplatin and Paclitaxel Plus Carboplatin in Advanced Nonsmall-Cell Lung Cancer
NCT00723957 ·Status: COMPLETED ·Phase: PHASE2
-
Clinical Study of Neoadjuvant Chemotherapy and Immunotherapy Combined With Probiotics in Patients With Resectable NSCLC
NCT04699721 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-small Cell Lung Cancer That Was Removed By Surgery
NCT00324805 ·Status: COMPLETED ·Phase: PHASE3
-
Survival Study of Docetaxel and Carboplatin as Neo-Adjuvant Vs Adjuvant Chemotherapy in Early Stage NSLC
NCT00321334 ·Status: COMPLETED ·Phase: PHASE3
-
Carboplatin, Docetaxel, Bevacizumab, and Erlotinib Versus Chemotherapy Alone in Resected NSCLC
NCT00621049 ·Status: COMPLETED ·Phase: PHASE2
-
TAilored Post-Surgical Therapy in Early Stage NSCLC
NCT00775385 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Nivolumab With or Without Ipilimumab or Chemotherapy in Treating Patients With Previously Untreated Stage I-IIIA Non-small Cell Lung Cancer
NCT03158129 ·Status: COMPLETED ·Phase: PHASE2
-
A Phase IIA Study of MK0457 in Patients With Cancer of the Lung (0457-006)
NCT00290550 ·Status: TERMINATED ·Phase: PHASE2
-
A Study of Neoadjuvant Chemotherapy Plus Nivolumab Versus Neoadjuvant Chemotherapy Plus Placebo, Followed by Surgical Removal and Adjuvant Treatment With Nivolumab or Placebo for Participants With Surgically Removable Early Stage Non-small Cell Lung Cancer
NCT04025879 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Preoperative Chemotherapy and Bevacizumab in Patients With Stage IB (>4 cm), II, or Select Stage III NSCLC
NCT00960297 ·Status: TERMINATED ·Phase: PHASE2
-
Efficacy Trial of Gemcitabine Containing Regimens As Preoperative Chemotherapy in Non Small Cell Lung Cancer
NCT00191256 ·Status: COMPLETED ·Phase: PHASE2
-
Induction Gemcitabine & Carboplatin Followed by Paclitaxel & Carboplatin +XRT in NSCLC
NCT00226590 ·Status: COMPLETED ·Phase: PHASE2
-
Neoadjuvant or Adjuvant Chemotherapy in Patients With Operable Non-small-cell Lung Cancer
NCT00913705 ·Status: COMPLETED ·Phase: PHASE3
-
Alternating Cycles of Carboplatin/Gemcitabine and Carboplatin/Taxol for Advanced Stage NSCLC
NCT00259675 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Efficacy of Carboplatin/Paclitaxel and Carboplatin/Paclitaxel/Bevacizumab With and Without Pictilisib in Previously Untreated Advanced or Recurrent Non-small Cell Lung Cancer
NCT01493843 ·Status: COMPLETED ·Phase: PHASE2
-
Chemotherapy/Radiotherapy Versus Concomitant Chemotherapy Followed by Radiotherapy in Stage IIIB Non-small Cell Lung Cancer
NCT01652820 ·Status: COMPLETED ·Phase: PHASE2
-
Three Modalities of Treatment in Operable and Resectable Stage IIIA (T1-3, N2) Non-Small Cell Lung Cancer (NSCLC)
NCT00198367 ·Status: COMPLETED ·Phase: PHASE2
-
Stage I/II NSCLC Perioperative Chemotherapy
NCT00198354 ·Status: COMPLETED ·Phase: PHASE3
-
Carboplatin and Gemcitabine Combined With Celecoxib and/or Zileuton in Treating Patients With Advanced Non-Small Cell Lung Cancer
NCT00070486 ·Status: COMPLETED ·Phase: PHASE2
-
Phase II Trial of Dose-dense Paclitaxel and Cisplatin as Neo-adjuvant Chemotherapy for Operable Stage II and IIA NSCLC
NCT00291850 ·Status: TERMINATED ·Phase: PHASE2